BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The surge of ground-breaking updates in Geographic Atrophy\, a
 long with significant advancements in developing robust biomarkers and fu
 nctional endpoints\, has ignited a wave of innovation in the field of oph
 thalmic drug development.\n\nThe 5th Dry AMD and GA Therapeutics Summit w
 ill unite 80+ biopharma stakeholders\, from discovery to early clinical d
 evelopment\, across three days of focused discussion. This summit is the 
 definitive forum for KOLs\, industry experts\, and regulators to drive th
 e next generation of dry AMD and Geographic Atrophy therapeutics forward.
 \n\nJoin us to explore the latest in preclinical models\, optimize trial 
 strategies\, and overcome safety and regulatory challenges to supercharge
  your pipeline.\n\nURLs:Tickets: https://go.evvnt.com/2621490-2?pid=185Br
 ochure: https://go.evvnt.com/2621490-3?pid=185\n\nTime: 9:00 AM - 5:00 PM
 \n\nSpeakers: Abraham Scaria\, Chief Scientific Officer\, Beacon Therapeu
 tics\, Anitha Krishnan\, Executive Director - Research\, Aviceda Therapeu
 tics\, Anneke Hollander\, Head of Cellular Genomics\, Genome Biology and 
 Functional Genomics\, Abbvie\, Brian Levy\, CEO\, Ocunexus Therapeutics\,
  Christine Curcio\, Ophthalmology and Visual Sciences Professor\, Univers
 ity of Alabama at Birmingham\, Cynthia Tung\, Medical Director Ophthalmol
 ogy\, Boehringer Ingelheim\, Daniela Ferrara\, Principal Medical Director
 \, Genentech\, David Zacks\, Chief Scientific Officer/Chief Medical Offic
 er\, ONL Therapeutics\, Deepayan Kar\, Biomarker Scientist\, Apellis Phar
 maceuticals\, Dennis Giesing\, Translational Medicine Consultant\, GelMED
 IX\, Fnu Ruchi\, Scientist\, National Eye Institute\, Harshal Shah\, Head
  of Device Strategy and Innovation\, Sanofi\, Justin Creel\, Head Of Targ
 eted Therapeutics Delivery Center\, Novartis\, Nehal Mehta\, Chief Execut
 ive Officer\, Mobius Scientific\, Peter de Haan\, Chief Scientific Office
 r and Co-founder\, Amarna Therapeutics\, Rajesh Rao\, Ophthalmology and V
 isual Sciences Professor\, University of Michigan\, Samarendra Mohanty\, 
 Chief Scientific Officer\, Nanoscope Therapeutics\, Samuel Lessard\, Prin
 cipal Genetics Scientist\, Sanofi\, Vicken Karageozian\, Chief Executive 
 Officer\, Allegro Ophthalmics\n
DTEND:20241030T170000
DTSTAMP:20260512T220337Z
DTSTART:20241028T090000
LOCATION:Wyndham Boston Beacon Hill\, 5\, Blossom Street\, Boston\, Massac
 husetts\, 02114\,
SEQUENCE:0
SUMMARY:The surge of ground-breaking updates in Geographic Atrophy\, along
  with significant advancements in developing robust biomarkers and functi
 onal endp...
UID:eb20028f-620b-432b-a67c-a73a579710f2
END:VEVENT
END:VCALENDAR